Effects of Saw Palmetto Extract on Urodynamic Parameters, Bladder Muscarinic and Purinergic Receptors and Urinary Cytokines in Rats with Cyclophosphamide-Induced Cystitis

scientific article published on 15 March 2013

Effects of Saw Palmetto Extract on Urodynamic Parameters, Bladder Muscarinic and Purinergic Receptors and Urinary Cytokines in Rats with Cyclophosphamide-Induced Cystitis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1111/LUTS.12015
P698PubMed publication ID26663502

P2093author name stringYoshihiko Ito
Shizuo Yamada
Eiji Masuda
Haruna Kugaya
Sweety Nasrin
Ayaka Osano
P2860cites workCyclophosphamide cystitis—Identification of acrolein as the causative agentQ28327805
Automated noninvasive measurement of cyclophosphamide-induced changes in murine voiding frequency and volumeQ31931194
Mast cell involvement in interstitial cystitis: a review of human and experimental evidenceQ34264766
Human prostatic steroid 5α-reductase isoforms—A comparative study of selective inhibitorsQ34296942
Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptomsQ34339703
Effect of the lipidosterolic extract of Serenoa repens (Permixon) and its major components on basic fibroblast growth factor-induced proliferation of cultures of human prostate biopsiesQ34465183
A detailed safety assessment of a saw palmetto extractQ36843661
Multiplex analysis of urinary cytokine levels in rat model of cyclophosphamide-induced cystitisQ37143576
Chronic pelvic pain syndrome and the overactive bladder: the inflammatory linkQ37258893
Pharmacological effects of saw palmetto extract in the lower urinary tractQ37406930
Hexanic lipidosterolic extract of Serenoa repens inhibits the expression of two key inflammatory mediators, MCP-1/CCL2 and VCAM-1, in vitroQ39361571
Saw palmetto extracts potently and noncompetitively inhibit human alpha1-adrenoceptors in vitroQ40968841
Cyclophosphamide cystitis as a model of visceral pain in rats: model elaboration and spinal structures involved as revealed by the expression of c-Fos and Krox-24 proteinsQ42274829
Inhibition of inflammatory gene expression in keratinocytes using a composition containing carnitine, thioctic Acid and saw palmetto extractQ42820918
Loss of muscarinic and purinergic receptors in urinary bladder of rats with hydrochloric acid-induced cystitisQ42933872
Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysisQ44900802
Alterations in P2X and P2Y purinergic receptor expression in urinary bladder from normal cats and cats with interstitial cystitis.Q44976700
Alteration of IL-17 related protein expressions in experimental autoimmune myocarditis and inhibition of IL-17 by IL-10-Ig fusion gene transferQ45877058
Isolation and pharmacological characterization of fatty acids from saw palmetto extractQ46054598
Effects of saw palmetto extract on micturition reflex of rats and its autonomic receptor binding activityQ46368348
Regional adaptation of muscarinic receptors and choline uptake in brain following repeated administration of diisopropylfluorophosphate and atropineQ46432562
Enhanced ATP release from rat bladder urothelium during chronic bladder inflammation: effect of botulinum toxin A.Q46560173
Altered muscarinic receptor subtype expression and functional responses in cyclophosphamide induced cystitis in ratsQ46672383
Alteration of muscarinic and purinergic receptors in urinary bladder of rats with cyclophosphamide-induced interstitial cystitisQ46677565
Epinephrine promotes hemostasis in rats with cyclophosphamide-induced hemorrhagic cystitisQ46983483
P2X and P2X receptor expression in human bladder urothelium and changes in interstitial cystitisQ47388087
The effects of cyclophosphamide on neurotransmission in the urinary bladder of Suncus murinus, the house musk shrew.Q52168818
BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay.Q53853603
P433issue1
P304page(s)57-63
P577publication date2013-03-15
P1433published inLower urinary tract symptomsQ27723063
P1476titleEffects of Saw Palmetto Extract on Urodynamic Parameters, Bladder Muscarinic and Purinergic Receptors and Urinary Cytokines in Rats with Cyclophosphamide-Induced Cystitis
P478volume6

Reverse relations

Q97067303A double blind, placebo-controlled randomized comparative study on the efficacy of phytosterol-enriched and conventional saw palmetto oil in mitigating benign prostate hyperplasia and androgen deficiencycites workP2860